CTOs on the Move

Gimbel Eye Centre

www.gimbel.com

 
Gimbel Eye Centre is a Calgary, AB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.gimbel.com
  • 4935 40 Ave NW
    Calgary, AB CAN T3A 2N1
  • Phone: 403.286.3022

Executives

Name Title Contact Details

Similar Companies

West End Mri

West End Mri is a Richmond, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

IASIS Healthcare Corporation

IASIS, located in Franklin, Tennessee, is a leading owner and operator of medium-sized acute care hospitals in high-growth urban and suburban markets. IASIS owns or leases 18 acute care hospital facilities and one behavioral health hospital facility with a total of 4,362 licensed beds and has total annual net revenue of approximately $2.8 billion. These hospital facilities are located in seven regions: Salt Lake City, Utah; Phoenix, Arizona; Tampa-St. Petersburg, Florida; five cities in Texas, including Houston and San Antonio; Las Vegas, Nevada; West Monroe, Louisiana; and Woodland Park, Colorado. IASIS also owns and operates a Medicaid and Medicare managed health plan in Phoenix that serves more than 197,000 members.

Kremer Eye Center

Kremer Eye Center is a King Of Prussia, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Southampton Hospital

The Mission of Southampton Hospital is to provide and ensure the highest quality of healthcare services for its entire community. The Vision of Southampton Hospital is to meet the evolving healthcare needs of its Eastern Long Island community by providing access to a continuum of high quality clinical services. To achieve this, the Hospital will focus resources on continuously improving clinical outcomes, patient safety, service excellence and promoting educational outreach and professional development of its staff.  

Highline Medical Group

Highline Medical Group is a Seattle, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.